The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Sabra Health Care REIT Inc. (SBRA) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.06, or -0.45%, to $13.31. Volume reached 26,088 shares, with price reaching a high of $12.83 and a low of $12.83. The stock was recently discussed on Yahoo Finance as it revealed that Sabra Health Care REIT, Inc. to Participate in the BofA Securities 2022 Global Real Estate Conference and 2022 NIC Fall Conference.
Sabra Health Care REIT Inc. is listed on the NASDAQ as a member of the Real Estate sector and is a part of the REIT – Healthcare Facilities industry. At the end of the last regular session, the stock closed at $12.83 and fluctuated between $13.33 as its day high and $12.67 as its day low. The current market capitalization of Sabra Health Care REIT Inc. is $3.02B. A total of 2.45 million shares were traded on the day, compared to an average of 1.85M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, SBRA has seen 10 BUY and 0 SELL insider trades, representing the acquisition of 15,295 and the disposition of 0 shares. Over the last 12 months, there were 55 BUYs and 6 SELLs from insiders. Insiders purchased 561,915 shares during that period but sold 501,458.
In the most recent transaction, Andrews Harold W. Jr. sold 110,000 shares of SBRA for 13.55 per share on Dec 29. After the transaction, the Executive VP, CFO & Secretary now owns 474,693 company shares.
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Sabra Health Care REIT Inc. pays an annual dividend of $1.20, resulting in a dividend yield of 9.35%, and it has a price to earnings (P/E) ratio of 68.61. SBRA’s most recent ex-dividend date was 08/16/2022 when it declared a $0.30 quarterly dividend that was paid in cash on 08/31/2022. Previously, the company paid the dividend on 05/31/2022 with an ex-dividend date of 05/13/2022. The dividend was $0.30 per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for SBRA in the last 3 months, the mean price target is $16.34 with high estimates of $20.00 and low estimates of $14.00. In terms of 52-week highs and lows, SBRA has a high of $16.60 and a low of $11.44.
As of this writing, SBRA has an earnings estimate of $0.37 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.39 per share and a lower estimate of $0.36. The company reported an EPS of $0.39 in the last quarter, which was 8.33% higher than expectations of $0.36.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SBRA’s latest balance sheet shows that the firm has $112.00M in Cash & Short Term Investments as of fiscal 2021. There were $2.39B in debt and $142.99M in liabilities at the time. Its Book Value Per Share was $14.36, while its Total Shareholder’s Equity was $3.38B.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 15 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SBRA is Underweight with a score of 3.80. A total of 6 analysts rated the stock as Buy while 1 rated it as Overweight while 8 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.